Fast and effective diagnostic test for the early detection of residual tumours to prevent cancer recurrence

Project Information

SenolT

Grant agreement ID: 826909

DOI 10.3030/826909

Project closed

EC signature date 23 July 2018

Start date 1 August 2018

End date 31 January 2019

Funded under

• INDUSTRIAL LEADERSHIP - Innovation In SMEs

Total cost € 71 429,00

EU contribution € 50 000,00

Coordinated by

SENOLYTIC THERAPEUTICS SL
Spain